Esophageal Candidiasis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: ESP018 MIFTS: 45	Esophageal Candidiasis Categories: Gastrointestinal diseases, Immune diseases, Infectious diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Esophageal Candidiasis

MalaCards integrated aliases for Esophageal Candidiasis:

Name: Esophageal Candidiasis ¹² ³ ¹⁵

Candidiasis of the Esophagus ¹² ⁷⁴

Esophageal Moniliasis ¹²

Candidal Esophagitis ¹²

Candida Esophagitis ¹²

Esophageal Thrush ¹²

Classifications:

MalaCards categories:
Global: Infectious diseases
Anatomical: Gastrointestinal diseases Immune diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:13146

ICD9CM ³⁶ 112.84

NCIt ⁵¹ C27027

SNOMED-CT ⁶⁹ 20639004

ICD10 ³⁴ B37.81

UMLS ⁷⁴ C0239295

Sources

Summaries for Esophageal Candidiasis

CDC : ³ Candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Candida normally lives inside the body (in places such as the mouth, throat, gut, and vagina) and on skin without causing any problems.1 Sometimes, Candida can multiply and cause an infection if the environment inside the mouth, throat, or esophagus changes in a way that encourages fungal growth.

MalaCards based summary : Esophageal Candidiasis, also known as candidiasis of the esophagus, is related to esophagitis, eosinophilic, 1 and laryngitis. An important gene associated with Esophageal Candidiasis is ATP12A (ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit), and among its related pathways/superpathways are Paroxetine Pathway, Pharmacokinetics and Statin Pathway - Generalized, Pharmacokinetics. The drugs Caspofungin and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include skin, myeloid and liver, and related phenotype is Decreased viability in esophageal squamous lineage.

Disease Ontology : ¹² A candidiasis that involves fungal infection of the esophagus by Candida albicans in immunocompromised people, resulting in lesions, bleeding, painful swallowing and substernal pain.

Wikipedia : ⁷⁷ Esophageal candidiasis is an opportunistic infection of the esophagus by Candida albicans. The disease... more...

Sources

Related Diseases for Esophageal Candidiasis

Diseases related to Esophageal Candidiasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 109)

#	Related Disease	Score	Top Affiliating Genes
1	esophagitis, eosinophilic, 1	30.4	ATP12A ATP4A
2	laryngitis	30.3	ATP12A ATP4A
3	esophageal varix	30.1	ATP12A ATP4A
4	peptic esophagitis	29.5	ATP12A ATP4A CYP2C19
5	candidiasis	10.9
6	acquired immunodeficiency syndrome	10.3
7	fungal esophagitis	10.3	ATP12A ATP4A
8	diclofenac allergy	10.3	ATP12A ATP4A
9	gastroduodenal crohn's disease	10.3	ATP12A ATP4A
10	neonatal candidiasis	10.3	ATP12A ATP4A
11	photoallergic dermatitis	10.3	ATP12A ATP4A
12	squamous papillomatosis	10.3	ATP12A ATP4A
13	toxic megacolon	10.3	ATP12A ATP4A
14	aspiration pneumonitis	10.3	ATP12A ATP4A
15	gastrointestinal neuroendocrine benign tumor	10.3	ATP12A ATP4A
16	gastric antral vascular ectasia	10.3	ATP12A ATP4A
17	granulomatous gastritis	10.3	ATP12A ATP4A
18	gastric neuroendocrine neoplasm	10.3	ATP12A ATP4A
19	acute laryngitis	10.3	ATP12A ATP4A
20	duodenitis	10.3	ATP12A ATP4A
21	rumination disorder	10.3	ATP12A ATP4A
22	active peptic ulcer disease	10.3	ATP12A ATP4A
23	congenital disorder of deglycosylation	10.3	ATP12A ATP4A
24	bladder calculus	10.3	ATP12A ATP4A
25	ischemic neuropathy	10.2	ATP12A ATP4A
26	bile reflux	10.2	ATP12A ATP4A
27	capillary disease	10.2	ATP12A ATP4A
28	dyskinesia of esophagus	10.2	ATP12A ATP4A
29	anismus	10.2	ATP12A ATP4A
30	postsurgical hypothyroidism	10.2	ATP12A ATP4A
31	lymphocytic colitis	10.2	ATP12A ATP4A
32	esophageal atresia/tracheoesophageal fistula	10.2	ATP12A ATP4A
33	clostridium difficile colitis	10.2	ATP12A ATP4A
34	diarrhea 1, secretory chloride, congenital	10.2	ATP12A ATP4A
35	microscopic colitis	10.2	ATP12A ATP4A
36	laryngeal tuberculosis	10.2	ATP12A ATP4A
37	eosinophilic gastritis	10.2	ATP12A ATP4A
38	esophagus adenocarcinoma	10.2	ATP12A ATP4A
39	chronic intestinal vascular insufficiency	10.2	ATP12A ATP4A
40	polyposis, skin pigmentation, alopecia, and fingernail changes	10.2	ATP12A ATP4A
41	jejunoileitis	10.2	ATP12A ATP4A
42	pancreatic steatorrhea	10.2	ATP12A ATP4A
43	human immunodeficiency virus infectious disease	10.2
44	superior mesenteric artery syndrome	10.2	ATP12A ATP4A
45	gastric lymphoma	10.2	ATP12A ATP4A
46	lower urinary tract calculus	10.2	ATP12A ATP4A
47	myopathy, x-linked, with excessive autophagy	10.2	ATP12A ATP4A
48	aspiration pneumonia	10.2	ATP12A ATP4A
49	blind loop syndrome	10.2	ATP12A ATP4A
50	functional gastric disease	10.2	ATP12A ATP4A

Comorbidity relations with Esophageal Candidiasis via Phenotypic Disease Network (PDN): (show all 18)

Active Peptic Ulcer Disease	Acute Cystitis
Acute Kidney Failure	Bronchitis
Chronic Kidney Failure	Decubitus Ulcer
Deficiency Anemia	Esophageal Disease
Esophagitis	Familial Atrial Fibrillation
Heart Disease	Iron Deficiency Anemia
Ischemic Heart Disease	Neutropenia
Oral Candidiasis	Protein-Energy Malnutrition
Respiratory Failure	Swallowing Disorders

Graphical network of the top 20 diseases related to Esophageal Candidiasis:

Sources

Symptoms & Phenotypes for Esophageal Candidiasis

GenomeRNAi Phenotypes related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

²⁷

#	Description	GenomeRNAi Source Accession	Score	Top Affiliating Genes
1	Decreased viability in esophageal squamous lineage	GR00235-A	9.1	ATP12A CYP2C19 CYP2C9 DEFB4A IARS2 TAAR9

Sources

Drugs & Therapeutics for Esophageal Candidiasis

Drugs for Esophageal Candidiasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 43)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Caspofungin

Approved

Phase 3,Phase 2,Not Applicable

162808-62-0, 179463-17-3

2826718 468682

Miconazole

Approved, Investigational, Vet_approved

Phase 3,Phase 2,Phase 1,Not Applicable

22916-47-8

4189

Micafungin

Approved, Investigational

Phase 3,Phase 1

235114-32-6

477468 3081921

Fluconazole

Approved, Investigational

Phase 3,Not Applicable

86386-73-4

3365

Clotrimazole

Approved, Vet_approved

Phase 3

23593-75-1

2812

Itraconazole

Approved, Investigational

Phase 3,Not Applicable

84625-61-6

55283

Voriconazole

Approved, Investigational

Phase 3

137234-62-9

71616

Antifungal Agents

Phase 3,Phase 2,Phase 1,Not Applicable

Anti-Infective Agents

Phase 3,Phase 2,Phase 1,Not Applicable

Hormones

Phase 3,Phase 2,Not Applicable

Hormone Antagonists

Phase 3,Phase 2,Not Applicable

Steroid Synthesis Inhibitors

Phase 3,Not Applicable

Cytochrome P-450 Enzyme Inhibitors

Phase 3,Not Applicable

Cytochrome P-450 CYP2C9 Inhibitors

Phase 3,Not Applicable

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 3,Phase 2,Not Applicable

Cytochrome P-450 CYP2C19 Inhibitors

Phase 3,Not Applicable

Pharmaceutical Solutions

Phase 3,Not Applicable

Cytochrome P-450 CYP3A Inhibitors

Phase 3,Not Applicable

Hydroxyitraconazole

Phase 3,Not Applicable

Acyclovir

Approved

Phase 2

59277-89-3

2022

Anidulafungin

Approved, Investigational

Phase 2

166663-25-8

166548

Midazolam

Approved, Illicit

Phase 2

59467-70-8

4192

Budesonide

Approved

Phase 2

51333-22-3

5281004 63006

Fluticasone

Approved, Experimental

Phase 2

90566-53-3

62924

Antiviral Agents

Phase 2

Antibiotics, Antitubercular

Phase 2

Anti-Bacterial Agents

Phase 2,Not Applicable

Bronchodilator Agents

Phase 2

Respiratory System Agents

Phase 2

Autonomic Agents

Phase 2

glucocorticoids

Phase 2

Anti-Asthmatic Agents

Phase 2

Peripheral Nervous System Agents

Phase 2

Anti-Inflammatory Agents

Phase 2

Anti-Allergic Agents

Phase 2

Dermatologic Agents

Phase 2

Echinocandins

Phase 1

Amphotericin B

Approved, Investigational

Not Applicable

1397-89-3

5280965 14956

Ketoconazole

Approved, Investigational

Not Applicable

65277-42-1

47576

Antiparasitic Agents

Not Applicable

Antiprotozoal Agents

Not Applicable

Liposomal amphotericin B

Not Applicable

Anti-Retroviral Agents

Interventional clinical trials:

(show all 25)

#	Name	Status	NCT ID	Phase	Drugs
1	A Study of Caspofungin Acetate (MK0991) for the Treatment of Esophageal Candidiasis or Invasive Candidiasis in Chinese Adults (MK-0991-066)	Completed	NCT00635648	Phase 3	caspofungin acetate
2	Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis	Completed	NCT00666185	Phase 3	Micafungin;Fluconazole
3	Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis	Completed	NCT00665639	Phase 3	micafungin;caspofungin
4	A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems	Completed	NCT00002339	Phase 3	Fluconazole
5	Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081)	Completed	NCT00000676	Phase 3	Clotrimazole;Fluconazole
6	A Clinical Study of MK0991 (Caspofungin) in Japanese Patients With Deep-seated Candida or Aspergillus Infections (0991-062)(COMPLETED)	Completed	NCT00717860	Phase 3	caspofungin acetate;Comparator: Micafungin sodium
7	A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection	Completed	NCT00784368	Phase 3	ITCZ Oral Solution;ITCZ-IV
8	A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients	Terminated	NCT01092832	Phase 3	voriconazole
9	Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda	Completed	NCT00405821	Phase 2	Acyclovir;Placebo
10	The Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)	Completed	NCT00041704	Phase 2	Anidulafungin, VER002
11	A Study of Caspofungin (MK-0991) in Japanese Children and Adolescents With Documented Candida or Aspergillus Infections (MK-0991-074)	Completed	NCT01165320	Phase 2	Caspofungin
12	Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis	Completed	NCT00762073	Phase 2	budesonide;placebo
13	Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)	Active, not recruiting	NCT03191864	Phase 2	APT-1011;Placebo
14	Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Completed	NCT00607763	Phase 1	Micafungin (Mycamine)
15	Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug	Completed	NCT00608335	Phase 1	Micafungin
16	Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.	Completed	NCT00002132	Not Applicable	Itraconazole;Fluconazole
17	Evaluation of Amphotericin B in the Treatment of Biopsy Proven Candida Esophagitis in Immunocompromised Patients	Completed	NCT00002041	Not Applicable	Amphotericin B
18	A Study of the Side Effects of L-743,872 in Men With Candidal Esophagitis	Completed	NCT00005921	Not Applicable	L-743,872
19	A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems	Completed	NCT00002304	Not Applicable	Ketoconazole;Fluconazole
20	A Randomized, Prospective, Double-Blind Study Comparing Fluconazole With Placebo for Primary and Secondary Prophylaxis of Mucosal Candidiasis in HIV-Infected Women	Completed	NCT00000744	Not Applicable	Fluconazole
21	A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected Patients	Completed	NCT00002438	Not Applicable	Itraconazole
22	HIV Cohort Study At Johns Hopkins University, University of North Carolina at Chapel Hill and Vanderbilt University	Completed	NCT01339416
23	Non-interventional Study for Prevention and Treatment of Fungal Infections in Paediatric Patients in Asia/Oceania - ERADICATE Study	Completed	NCT03174457		Micafungin
24	Kaiser Permanente HIV Cohort Study	Completed	NCT01339403
25	A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I Infection	Withdrawn	NCT01692470		No intervention

Search NIH Clinical Center for Esophageal Candidiasis

Sources

Genetic Tests for Esophageal Candidiasis

Sources

Anatomical Context for Esophageal Candidiasis

MalaCards organs/tissues related to Esophageal Candidiasis:

⁴²

Skin, Myeloid, Liver, Kidney, Colon, Testes, Bone

Sources

Publications for Esophageal Candidiasis

Articles related to Esophageal Candidiasis:

(show top 50) (show all 122)

#	Title	Authors	Year
1	Course of Esophageal Candidiasis and Outcomes of Patients at a Single Center. ( 29702297 )	Hoversten P...Katzka DA	2019
2	Cytology Preparations of Formalin Fixative Aid Detection of Giardia in Duodenal Biopsy Samples: A Helpful Tool for Diagnosing Esophageal Candidiasis as Well? ( 29762142 )	Schr?der S...G?nther T	2018
3	Predictors of esophageal candidiasis among patients attending endoscopy unit in a tertiary hospital, Tanzania: a retrospective cross-sectional study. ( 29977259 )	Mushi MF...Mshana SE	2018
4	Recurrent episodes of esophageal candidiasis without dysphagia post-Guillain-Barré syndrome: an unusual presentation of achalasia. ( 29038193 )	Runggaldier D...Pohl D	2017
5	Challenges to "Classic" Esophageal Candidiasis: Looks Are Usually Deceiving. ( 28158394 )	Alsomali MI...Arnold CA	2017
6	Narrow-band imaging can increase the visibility of fibrin caps after bleeding of esophageal varices: a case with extensive esophageal candidiasis. ( 28500570 )	Furuichi Y...Itoi T	2017
7	Safety, Efficacy, and Exposure-Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis. ( 27636722 )	Martin JM...Aram JA	2017
8	Epigastric Distress Caused by Esophageal Candidiasis in 2 Patients Who Received Sorafenib Plus Radiotherapy for Hepatocellular Carcinoma: Case Report. ( 26986168 )	Chen KH...Hsieh CH	2016
9	Invasive Esophageal Candidiasis with Chronic Mediastinal Abscess and Fatal Pneumomediastinum. ( 27389822 )	Aghdam MR...Sund S	2016
10	A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis. ( 25561337 )	Viljoen J...Ghannoum M	2015
11	A patient with chronic diarrhea, recurrent infections, and oropharyngeal and esophageal candidiasis. ( 25478924 )	Coppens G...Baert F	2015
12	Aphagia due to esophageal candidiasis in an immunocompetent patient. ( 25194226 )	Ruiz Pardo J...Munitiz Ruiz V	2015
13	Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients. ( 26208220 )	Takahashi Y...Uemura N	2015
14	The clinical course of asymptomatic esophageal candidiasis incidentally diagnosed in general health inspection. ( 26083902 )	Lee SP...Shim CS	2015
15	Esophageal Candidiasis as the Initial Manifestation of Acute Myeloid Leukemia. ( 26631899 )	Komeno Y...Ryu T	2015
16	Antifungal Treatment is Not Required for Immunocompetent Individuals With Asymptomatic Esophageal Candidiasis. ( 26559270 )	Min YW...Rhee PL	2015
17	The potential of photodynamic therapy to treat esophageal candidiasis coexisting with esophageal cancer. ( 24378331 )	Qiu H...Yang Y	2014
18	Is empiric therapy with fluconazole appropriate for esophageal candidiasis? ( 24424852 )	Sajith KG...Chacko A	2014
19	Relationship between clinical factors and severity of esophageal candidiasis according to Kodsi's classification. ( 23826847 )	Asayama N...Uemura N	2014
20	Factors associated with esophageal candidiasis and its endoscopic severity in the era of antiretroviral therapy. ( 23555571 )	Nishimura S...Uemura N	2013
21	Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. ( 23225813 )	Choi JH...Choi JS	2013
22	Clinical pharmacodynamic index identification for micafungin in esophageal candidiasis: dosing strategy optimization. ( 23959319 )	Andes DR...Bhavnani SM	2013
23	A case of esophageal candidiasis in an adolescent who had frequently received budesonide nebulizing therapy. ( 24224152 )	Kang HR...Kim YJ	2013
24	Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis. ( 21956255 )	Undre N...Baraldi E	2012
25	Association of esophageal candidiasis and squamous cell carcinoma. ( 24371724 )	Delsing CE...Netea MG	2012
26	Eosinophilic esophagitis misdiagnosed twice as esophageal candidiasis. ( 20152316 )	Infante JM...Lamana LF	2010
27	Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. ( 22096388 )	Vazquez JA	2010
28	In vitro activity of anidulafungin and other agents against esophageal candidiasis-associated isolates from a phase 3 clinical trial. ( 20504981 )	Pfaller MA...Henkel T	2010
29	Esophageal candidiasis in an immunocompetent girl. ( 19718541 )	Hasosah MY...Jacobson K	2009
30	Esophageal candidiasis--an adverse effect of inhaled corticosteroids therapy. ( 19484677 )	Aun MV...Giavina-Bianchi P	2009
31	The resistance to fluconazole in patients with esophageal candidiasis. ( 19466307 )	Wilheim AB...Pereira LM	2009
32	Giardiasis diagnosed on esophageal brush smears in a case of chronic alcoholic liver disease with esophageal candidiasis. ( 18831025 )	Singh DK...Gondal R	2008
33	The impact of esophageal candidiasis on hospital charges and costs across patient subgroups. ( 18036287 )	Tong KB...Seifeldin R	2008
34	Safety and efficacy of posaconazole in the long-term treatment of azole-refractory oropharyngeal and esophageal candidiasis in patients with HIV infection. ( 17507324 )	Vazquez JA...Isaacs R	2007
35	A murine model of esophageal candidiasis with local characteristic symptoms. ( 17579259 )	Ishibashi H...Abe S	2007
36	An elderly case of type 2 diabetes which developed in association with oral and esophageal candidiasis. ( 17409603 )	Takasawa H...Noda M	2007
37	Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. ( 17243069 )	Skiest DJ...Isaacs R	2007
38	Caspofungin-resistant oral and esophageal candidiasis in a patient with AIDS. ( 17148982 )	Jokela JA...Kaur P	2007
39	Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. ( 18034973 )	Mullaoglu S...Kustimur S	2007
40	Possible aggravation and recovery of slowly progressive type 1 diabetes by onset and resolution of oral and esophageal candidiasis. ( 17878660 )	Goto A...Noda M	2007
41	Role of posaconazole in the management of oropharyngeal and esophageal candidiasis. ( 18472974 )	Vazquez JA	2007
42	Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients. ( 16757256 )	Veroux M...Veroux P	2006
43	Esophageal candidiasis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP). ( 16724573 )	Kobayashi Y...Kita H	2006
44	Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome. ( 16127030 )	Kartsonis N...Motyl M	2005
45	Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. ( 15984964 )	Mocroft A...EuroSIDA study group	2005
46	Esophageal candidiasis. ( 16408552 )	Golub JS...Johns MM	2005
47	Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans. ( 15388459 )	Petraitis V...Walsh TJ	2004
48	A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis. ( 15472806 )	Krause DS...Henkel T	2004
49	A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. ( 15472817 )	de Wet N...Diekmann-Berndt H	2004
50	Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them. ( 15472818 )	Darouiche RO	2004

Sources

Genes for Esophageal Candidiasis

Genes related to Esophageal Candidiasis (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	ATP12A	ATPase H+/K+ Transporting Non-Gastric Alpha2 Subunit	Protein Coding	15.94	DISEASES inferred ¹⁵
2	ATP4A	ATPase H+/K+ Transporting Subunit Alpha	Protein Coding	15.93	DISEASES inferred ¹⁵
3	IARS2	Isoleucyl-TRNA Synthetase 2, Mitochondrial	Protein Coding	15.33	DISEASES inferred ¹⁵
4	TAAR9	Trace Amine Associated Receptor 9 (Gene/Pseudogene)	Protein Coding	15.09	DISEASES inferred ¹⁵
5	CYP2C9	Cytochrome P450 Family 2 Subfamily C Member 9	Protein Coding	14.92	DISEASES inferred ¹⁵
6	CYP2C19	Cytochrome P450 Family 2 Subfamily C Member 19	Protein Coding	14.86	DISEASES inferred ¹⁵
7	DEFB4A	Defensin Beta 4A	Protein Coding	14.82	DISEASES inferred ¹⁵

Sources

Variations for Esophageal Candidiasis

Sources

Expression for Esophageal Candidiasis

Search GEO for disease gene expression data for Esophageal Candidiasis.

Sources

Pathways for Esophageal Candidiasis

Pathways related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Paroxetine Pathway, Pharmacokinetics ⁶² Show member pathways Amitriptyline and Nortriptyline Pathway, Pharmacokinetics ⁶² Citalopram Pathway, Pharmacokinetics ⁶² Clomipramine Pathway, Pharmacokinetics ⁶² Clopidogrel Pathway, Pharmacokinetics ⁶² Clozapine Pathway, Pharmacokinetics ⁶² Doxepin Pathway, Pharmacokinetics ⁶² Fluoxetine Pathway, Pharmacokinetics ⁶² Gefitinib Pathway, Pharmacokinetics ⁶² Imipramine/Desipramine Pathway, Pharmacokinetics ⁶² Nevirapine Pathway, Pharmacokinetics ⁶² Olanzapine Pathway, Pharmacokinetics ⁶² Pazopanib Pathway, Pharmacokinetics ⁶² Proton Pump Inhibitor Pathway, Pharmacokinetics ⁶² Venlafaxine Pathway, Pharmacokinetics ⁶² Verapamil Pathway, Pharmacokinetics ⁶² Warfarin Pathway, Pharmacokinetics ⁶²	11.5	CYP2C19 CYP2C9
2	Statin Pathway - Generalized, Pharmacokinetics ⁶² Show member pathways Anti-diabetic Drug Nateglinide Pathway, Pharmacokinetics ⁶² Anti-diabetic Drug Repaglinide Pathway, Pharmacokinetics ⁶² Atorvastatin/Lovastatin/Simvastatin Pathway, Pharmacokinetics ⁶² Clobazam Pathway, Pharmacokinetics ⁶² Diclofenac Metabolic Pathway ¹ Diclofenac Pathway, Pharmacokinetics ⁶² Fluvastatin Pathway, Pharmacokinetics ⁶² Ibuprofen Pathway, Pharmacokinetics ⁶² Pravastatin Pathway, Pharmacokinetics ⁶² Rosiglitazone Pathway, Pharmacokinetics ⁶² Rosuvastatin Pathway, Pharmacokinetics ⁶²	11.46	CYP2C19 CYP2C9
3	Phenytoin Pathway, Pharmacokinetics ⁶² Show member pathways Atomoxetine Pathway, Pharmacokinetics ⁶² Carbamazepine Pathway, Pharmacokinetics ⁶² Cyclophosphamide Pathway, Pharmacokinetics ⁶² Efavirenz Pathway, Pharmacokinetics ⁶² Sorafenib Pharmacokinetics ⁶²	11.13	CYP2C19 CYP2C9
4	Androstenedione and testosterone biosynthesis and metabolism p.1 ²³ Show member pathways Estrogen biosynthesis ²³ Estrone metabolism ²³ Steroid Biosynthesis ¹	10.99	CYP2C19 CYP2C9
5	Platelet Aggregation Inhibitor Pathway, Pharmacodynamics ⁶²	10.86	CYP2C19 CYP2C9
6	Tamoxifen metabolism ¹ Show member pathways Tamoxifen Pathway, Pharmacokinetics ⁶²	10.55	CYP2C19 CYP2C9
7	Constitutive Androstane Receptor Pathway ¹	10.13	CYP2C19 CYP2C9

Sources

GO Terms for Esophageal Candidiasis

Cellular components related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	organelle membrane	GO:0031090	8.62	CYP2C19 CYP2C9

Biological processes related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

(show all 13)

#	Name	GO ID	Score	Top Affiliating Genes
1	xenobiotic metabolic process	GO:0006805	9.52	CYP2C19 CYP2C9
2	potassium ion import across plasma membrane	GO:1990573	9.51	ATP12A ATP4A
3	ATP hydrolysis coupled proton transport	GO:0015991	9.49	ATP12A ATP4A
4	drug metabolic process	GO:0017144	9.48	CYP2C19 CYP2C9
5	exogenous drug catabolic process	GO:0042738	9.46	CYP2C19 CYP2C9
6	organic acid metabolic process	GO:0006082	9.43	CYP2C19 CYP2C9
7	epoxygenase P450 pathway	GO:0019373	9.4	CYP2C19 CYP2C9
8	cellular sodium ion homeostasis	GO:0006883	9.37	ATP12A ATP4A
9	establishment or maintenance of transmembrane electrochemical gradient	GO:0010248	9.32	ATP12A ATP4A
10	cellular potassium ion homeostasis	GO:0030007	9.26	ATP12A ATP4A
11	sodium ion export across plasma membrane	GO:0036376	9.16	ATP12A ATP4A
12	omega-hydroxylase P450 pathway	GO:0097267	8.96	CYP2C19 CYP2C9
13	monoterpenoid metabolic process	GO:0016098	8.62	CYP2C19 CYP2C9

Molecular functions related to Esophageal Candidiasis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	GO:0016705	9.4	CYP2C19 CYP2C9
2	monooxygenase activity	GO:0004497	9.37	CYP2C19 CYP2C9
3	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen	GO:0016712	9.32	CYP2C19 CYP2C9
4	steroid hydroxylase activity	GO:0008395	9.26	CYP2C19 CYP2C9
5	arachidonic acid epoxygenase activity	GO:0008392	9.16	CYP2C19 CYP2C9
6	sodium:potassium-exchanging ATPase activity	GO:0005391	8.96	ATP12A ATP4A
7	potassium:proton exchanging ATPase activity	GO:0008900	8.62	ATP12A ATP4A

Sources

Sources for Esophageal Candidiasis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FDA Approved Drugs

²⁰ FMA

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ Genetics Home Reference

²⁷ GenomeRNAi

²⁸ GEO DataSets

²⁹ GO

³⁰ GTR

³¹ HGMD

³² HMDB

³³ HPO

³⁴ ICD10

³⁵ ICD10 via Orphanet

³⁶ ICD9CM

³⁷ IUPHAR

³⁸ KEGG

³⁹ LifeMap

⁴⁰ LncRNADisease

⁴¹ LOVD

⁴² MalaCards

⁴³ MedGen

⁴⁴ MedlinePlus

⁴⁵ MeSH

⁴⁶ MESH via Orphanet

⁴⁷ MGI

⁴⁸ miR2Disease

⁴⁹ NCBI Bookshelf

⁵⁰ NCI

⁵¹ NCIt

⁵² NDF-RT

⁵³ NIH Clinical Center

⁵⁴ NIH Rare Diseases

⁵⁵ NINDS

⁵⁶ Novoseek

⁵⁷ Novus Biologicals

⁵⁸ OMIM

⁵⁹ OMIM via Orphanet

⁶⁰ Orphanet

⁶¹ PathCards

⁶² PharmGKB

⁶³ PubMed

⁶⁴ PubMed Health

⁶⁵ QIAGEN

⁶⁶ R&D Systems

⁶⁷ Reactome

⁶⁸ Sino Biological

⁶⁹ SNOMED-CT

⁷⁰ SNOMED-CT via HPO

⁷¹ SNOMED-CT via Orphanet

⁷² TGDB

⁷³ Tocris

⁷⁴ UMLS

⁷⁵ UMLS via Orphanet

⁷⁶ UniProtKB/Swiss-Prot

⁷⁷ Wikipedia